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Abstract Uncoupling protein 2 (UCP2) expression in liver is
restricted to non-parenchymal cells. By means of differential
display screening between normal rat liver and H4IIE hepatoma
cells we have isolated a cDNA clone encompassing part of UCP2
cDNA. Northern blot analysis revealed that UCP2 is expressed
in some hepatocarcinoma cell lines, while it is absent in adult
hepatocytes. UCP2 mRNA in H4IIE cells was downregulated
when cells were cultured for 36 h in 0.1% serum and its
expression was restored upon addition of 10% serum or phorbol
esters. Hypomethylation of UCP2 was observed in transformed
UCP2 expressing cells. Our results indicate that UCP2 is
expressed in some hepatocarcinoma cell lines and that serum
components may participate in maintaining elevated UCP2
levels.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Hepatocellular carcinoma (HCC) is one of the most fre-
quent gastrointestinal cancers in the world population [1].
Neoplastic transformation of the liver is a complex and multi-
step process which involves multiple genetic abnormalities.
The inactivation of tumor suppressor genes and the activation
of oncogenes and cell growth related genes [2,3] are among the
genetic changes which may participate in the development of
the neoplastic phenotype. However, a better understanding of
the molecular biology of HCC is still needed in order to facil-
itate the development of new therapeutic strategies and diag-
nostic procedures. With this aim we have performed di¡er-
ential display (DD) analysis [4] between normal rat liver and
the rat hepatoma cell line H4IIE as a model of transformed
hepatic cell.
One of the genes identi¢ed as overexpressed in the H4IIE
cells with respect to normal liver was the recently cloned un-
coupling protein 2 (UCP2), a member of a family of proton
channels located in the inner mitochondrial membrane [5].
UCP1 was the ¢rst member of this family of mitochondrial
uncouplers to be identi¢ed [6], and is exclusively expressed in
brown adipose tissue, where it mediates heat generation and
calorie burning through the dissipation of the electrochemical
gradient across the inner mitochondrial membrane [7]. UCP2,
which also alters mitochondrial potential when expressed in
yeast [5], is more widely expressed in rat and human tissues
[5,8], however the low levels of UCP2 mRNA detected in liver
are restricted to non-parenchymal cells [9,10]. In the present
work we have evaluated UCP2 expression in human HCC cell
lines and studied possible mechanisms behind UCP2 induc-
tion, such as serum dependence and potential signaling sys-
tems involved. Given the prominent role that altered DNA
methylation may play in the regulation of gene expression
during carcinogenesis [11], we also studied UCP2 methylation
status in normal and transformed cells in order to identify the
potential molecular mechanisms leading to UCP2 mRNA in-
duction.
2. Materials and methods
2.1. Cell lines and culture conditions
The rat H4IIE hepatoma cells and the human HepG2, Hep3B, SK-
HEP-1 and HuH-7 HCC derived cell lines were obtained from the
American Type Culture Collection (ATCC, Manassas, VA). Cells
were maintained in Dulbecco’s modi¢ed Eagle medium supplemented
with 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin and
100 Wg/ml streptomycin at 37‡C in a humidi¢ed atmosphere of 5%
CO2 in air.
2.2. DD analysis
Total cellular RNA was isolated by extraction with guanidinium
thiocyanate followed by centrifugation in a cesium chloride solution
as previously described [12]. 25 Wg of total RNA was incubated for
30 min at 37‡C with 10 units of RNase-free DNase I (Boehringer
Mannheim, Mannheim, Germany) in 10 mM Tris pH 7.5, 10 mM
MgCl2, phenol-chloroform extracted, ethanol precipitated, and redis-
solved in sterile nuclease-free water.
Di¡erential display was performed using oligo(dT) anchored prim-
ers [4,12] with Hieroglyph mRNA Pro¢le Kit (Genomyx, Beckman
Instruments, Fullerton, CA) following the manufacturer’s instruc-
tions, in a Perkin Elmer GeneAmp 2400 thermal cycler. Reactions
were performed with each cDNA solution in duplicate. Control reac-
tions were set using sterile nuclease-free water or each DNase-treated
RNA instead of the cDNA solution.
Following DD-PCR, radiolabeled cDNA fragments were electro-
phoretically separated on 4.5% polyacrylamide gels under denaturing
conditions in a Genomyx LR DNA sequencer (Genomyx). Bands of
interest were excised from the gel, and the gel slides were placed
directly into PCR tubes. Reampli¢cation was performed using T7
promoter 22-mer and M13 reverse 24-mer primers. Ampli¢ed DNA
fragments were cloned into the plasmid vector pCR2.1-TOPO using
TOPO-TA Cloning Kit (Invitrogen, De Schelp, The Netherlands) and
sequenced in both directions using M13 reverse (324) primer and
M13 forward (320) primer. Nucleotide sequence homology search
analyses of the EMBL [13] and GenBank [14] databases were per-
formed using the program FASTA [15].
2.3. Northern blot analysis
Total RNA was isolated from hepatocytes and hepatoma cell lines
by the guanidinium thiocyanate method [16]. Aliquots (20 Wg) of total
RNA were size fractionated by electrophoresis in a 1% agarose gel
under denaturing conditions. RNAs were then blotted and ¢xed to
Nytran membranes (Schleicher and Schuell, Keene, NH). Prehybrid-
ization and hybridization were performed as previously described [17].
UCP2 mRNA was detected with the 0.6 kb cDNA probe obtained in
our DD analysis. The rat K-fetoprotein (AFP) probe was a generous
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gift of Dr. J.L. Danan (Centre de Recherche sur L’Endocrinologie,
Meudon, France). Probes were labeled with [K-32P]dCTP (3000 Ci/
mmol; Amersham, Little Chalfont, UK) by random priming using
the Megaprime DNA labeling system (Amersham). Speci¢c activity
was usually approximately 5U108 cpm/Wg of DNA. Quantitation was
performed by scanning densitometry of the X-ray ¢lms. The amount
and quality of the loaded RNA samples were evaluated by methylene
blue staining of the 28S and 18S rRNAs, and by hybridization with
the 36B4 cDNA [18].
2.4. DNA isolation, methylation analysis and Southern blot
High molecular weight DNAs from normal human liver and human
hepatoma HepG2 and Hep3B cells were prepared as previously de-
scribed [19]. 10 Wg of DNA was digested to completion with 5 U/Wg
MspI or HpaII (Boehringer Mannheim) by incubation at 37‡C for a
total of 6 h, enzyme was added in two aliquots at 3 h intervals.
Samples were then electrophoresed on 1% agarose gels and then trans-
ferred to Nytran membranes. Prehybridization and hybridization with
UCP2 cDNA probe were carried out as described [19]. Membranes
were then exposed to X-ray ¢lms.
3. Results
3.1. DD analysis
DD analysis was carried out between rat liver and the rat
hepatoma cell line H4IIE as described in Section 2. Several
bands were di¡erentially expressed in hepatoma cells as com-
pared to normal liver. One of the bands selected for analysis,
preferentially overexpressed in H4IIE cells (Fig. 1A), was ex-
cised from the gel, ampli¢ed and sequenced. Sequencing of 0.3
kb of the total 0.6 kb of this clone revealed 100% identity to
the rat UCP2 cDNA (nucleotides 502^865) [8], and could
hybridize 1.7 kb mRNA in total cellular RNA from rat liver
tissue and H4IIE cells (Fig. 1B). The band detected using
Northern analysis corresponded in size to that reported for
the UCP2 transcript in rat liver [8], and was induced about
14-fold in the rat hepatoma H4IIE cells.
3.2. Expression of UCP2 in human HCC cell lines
We next examined whether UCP2 mRNA was also present
in human HCC cell lines. Using our UCP2 cDNA clone as a
probe we carried out Northern blot analysis in four human
HCC cell lines. UCP2 mRNA was detected in two of four
HCC cell lines, HepG2 and HuH-7, while it was absent in
Hep3B and SK-HEP-1 cells (Fig. 2). Highest levels of UCP2
mRNA were detected in HepG2 cells and were comparable to
those present in the H4IIE cell line.
It is known that transformed hepatic cells may express a
number of genes which are characteristic of embryonic tissues,
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Fig. 1. DD analysis between normal rat liver and H4IIE cells.
A: Sequencing gel electrophoresis of PCR ampli¢ed cDNAs from
normal rat liver (1) and H4IIE cells (2). A di¡erentially displayed
fragment (arrow) was detected, isolated, reampli¢ed and upon se-
quencing was identi¢ed as part of UCP2 cDNA. B: Northern hy-
bridization analysis of total RNAs from normal rat liver (1) and
H4IIE cells (2), performed with the previously isolated cDNA frag-
ment, revealed a 1.7 kb band which was markedly induced in the
transformed cell line. Methylene blue staining of the blots was per-
formed as loading control. The migration of the ribosomal markers
is indicated.
Fig. 2. Expression of UCP2 in H4IIE cells (1) and the human HCC
cell lines HepG2 (2), Hu-H7 (3), Hep3B (4) and SK-HEP-1 (5) ana-
lyzed by Northern blotting of total RNA. The same blot was also
probed with AFP. Methylene blue staining of the blots was per-
formed as loading control.
Fig. 3. Methylation status of UCP2 in normal human liver, HepG2
and Hep3B cells. DNA was extracted and digested to completion
with MspI (M) and HpaII (H) as described in Section 2. Asterisks
indicate the location of new bands detected in MspI and HpaII di-
gested DNA from HepG2 cells.
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such as the AFP [20]. We have tested AFP expression in the
HCC cell lines mentioned above. Northern blot analysis dem-
onstrated a high level of AFP mRNA in SK-HEP-1, Hep3B
and HuH-7 cells, while no signal was detected in H4IIE or
HepG2 (Fig. 2).
3.3. UCP2 methylation status in normal liver and HCC cells
Possible changes in the methylation status of the UCP2
gene in transformed hepatic cells were examined. DNA iso-
lated from normal human liver and the human HCC cell lines
HepG2 and Hep3B was subjected to Southern blot analysis
after complete digestion with the restriction enzymes MspI
and HpaII. Both enzymes recognize the same sequence
(CCGG) but display di¡erential sensitivity to the presence
of 5-methyl-C [21,22]. HpaII cannot cleave if the internal C
is methylated, while methylation of the external C prevents
cleavage by both enzymes [23]. New bands were detected in
the HpaII and MspI treated DNA from the tumor cell line
HepG2 (Fig. 3), which may indicate hypomethylation of the
UCP2 gene. However, a similar restriction pattern was ob-
served between normal human liver DNA and Hep3B cells
which do not express UCP2 mRNA.
3.4. Serum levels modulate UCP2 expression in H4IIE cells
We next examined whether UCP2 mRNA levels in H4IIE
could respond to changes in the culture conditions in order to
identify possible environmental signals which may contribute
to UCP2 induction. For this purpose, cells growing in 10%
serum were shifted to medium containing 0.1% serum for 36 h
with the aim of depleting serum derived factors without chal-
lenging cellular viability. After this time we evaluated UCP2
mRNA content by Northern blotting. As shown in Fig. 4,
serum deprivation induced a signi¢cant decrease in UCP2
mRNA levels. To test whether this response was reversible,
fresh medium containing 0.1% or 10% serum was added back
to the cells. Serum refeeding resulted in the elevation of UCP2
mRNA, reaching values close to those observed in control
cells (10% serum) after 8 h of treatment. In order to gain
more insight into the mechanisms behind UCP2 mRNA in-
duction we examined the possible implication of some signal-
ing pathways commonly modulated by serum components.
For this purpose, serum starved cells were treated with the
phorbol ester PMA (10 WM), the cAMP inducing drug for-
skolin (10 WM) or the glucocorticoid triamcinolone (1 WM).
Upregulation of UCP2 mRNA levels was only observed in
response to PMA (Fig. 4), forskolin and triamcinolone treat-
ment did not have an e¡ect (data not shown).
4. Discussion
By means of DD analysis between normal rat liver tissue
and the HCC cell line H4IIE, we have isolated a 0.6 kb clone
that was preferentially expressed in the transformed hepatic
cells. Upon sequencing it was found that this clone corre-
sponded to part of the recently described UCP2 gene [5].
UCP2 is a member of the mitochondrial carrier protein family
which includes the 2-oxoglutarate/malate, the citrate and the
phosphate carriers, the ATP/ADP translocator and UCP1
[24]. The rat UCP2 cDNA has recently been cloned together
with UCP3, another new member of this family of proteins
[8]. UCP2 amino acid sequence shows 99% and 95% identity
with the mouse and human proteins respectively [5]. UCP2
expression has been detected in a wide variety of tissues
[5,8] including fetal liver [25], while UCP1 is con¢ned to
brown adipose tissue which is scarce in adult humans.
The high degree of identity between UCP2 proteins from
di¡erent species, its ability to alter mitochondrial potential
and its wide tissular distribution suggest that this gene
may play an important role in cellular energetics [26]. In spite
of the wide distribution of UCP2, its presence in liver has
been demonstrated to occur only in non-parenchymal cells,
mainly in Kup¡er cells [9,10]. Our initial observation of the
presence of UCP2 mRNA in rat H4IIE cells led us to examine
whether HCC cells of human origin could also express this
gene. We have found that UCP2 mRNA was present in two
out of four HCC cell lines examined, demonstrating that
UCP2 induction may also take place in transformed hepatic
cells of human origin. Interestingly, UCP2 expression was
detected in cell lines such as HepG2 which did not express
AFP mRNA, a common marker of hepatocellular transfor-
mation [20,27].
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Fig. 4. Serum and phorbol esters modulate UCP2 mRNA levels in
H4IIE cells. A: Cells growing in 10% serum were washed and refed
medium containing 0.1% serum (time point designated zero). After
36 h in low serum, cells were treated with fresh medium containing
10% serum (open squares), 0.1% serum plus 10 WM PMA (closed
circles) or 0.1% serum (open circles). UCP2 mRNA levels were de-
termined in each case, values represent the mean þ S.E.M. of three
independent experiments. B: Representative Northern blot assay
showing UCP2 mRNA in the various conditions mentioned above;
(1) cells growing in 10% serum, (2) cells after 36 h in 0.1% serum,
cells after 4 h (3) and 8 h (4) in fresh medium with 0.1% serum,
cells after 4 h (5) and 8 h (6) of treatment with 10% serum, cells
after 4 h (7) and 8 h (8) in the presence of fresh medium containing
0.1% serum plus 10 WM PMA. Blots were probed with 36B4 cDNA
as loading control.
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It is known that transformed cells display many metabolic
traits characteristic of the embryonic and fetal stages of devel-
opment [28,29]. In the case of liver cells the similarities be-
tween the fetal liver and the tumor cells are also evident at the
mitochondrial level [30,31]. The induction of UCP2 mRNA in
some HCC cell lines may be regarded as more evidence of the
reversion to a fetal phenotype in terms of energy metabolism.
In this sense, it has been proposed that mitochondria of tumor
cells are undi¡erentiated and behave in many senses like fetal
mitochondria [30,31].
Alterations in the pattern of gene expression participate in
the multistep process of carcinogenesis [12,32,33]. It is known
that changes in DNA methylation take place during neoplas-
tic transformation and may facilitate the aberrant pro¢le of
genes expressed in tumor cells [11,34]. In an e¡ort to identify
the possible molecular mechanisms behind the induction of
UCP2 gene expression in HCC cells, we have studied the
methylation status of this gene in normal human liver,
HepG2 and Hep3B cells. Our results show alterations in the
methylation pattern of UCP2 in HepG2 which are consistent
with DNA hypomethylation. However, in Hep3B cells, which
do not express UCP2, the methylation pattern was similar to
that observed in normal liver. It is interesting to note that the
induction of AFP expression in human HCC has also been
associated with hypomethylation of this gene [27], supporting
a role for DNA methylation in gene expression during hepatic
carcinogenesis.
In a search for other mechanisms which may contribute to
the presence of UCP2 transcripts in hepatocarcinoma cells, we
have explored the in£uence of environmental factors inherent
in the culture conditions of our cells which may participate in
this phenomenon. In this sense we have shown that UCP2
expression was substantially reduced in H4IIE cells when cul-
tures were serum starved. This e¡ect may indicate the involve-
ment of factors present in serum in the induction of UCP2
mRNA at least in this cell line. UCP2 mRNA levels were
restored shortly after reexposure to serum containing medium.
Interestingly, when serum starved cultures were treated with
the phorbol ester PMA UCP2 mRNA levels were also in-
duced, suggesting a role for PKC in the regulation of UCP2
expression in hepatocarcinoma cells. In this sense, it is worth
noting that an AP1 binding site has recently been described in
the strong positive regulatory region of the UCP2 promoter
[35]. Conversely, treatment with the cAMP inducing drug for-
skolin or the glucocorticoid triamcinolone did not have an
e¡ect on UCP2 mRNA levels, although glucocorticoid and
cAMP response elements have been also reported in the
UCP2 promoter [35].
Although the metabolic implications of UCP2 expression in
HCC cells remain to be determined, our observations contrib-
ute to the understanding of the biology of hepatic tumors.
Additionally the assessment of the presence of UCP2
mRNA in hepatocytes from liver biopsies may be of diagnos-
tic interest.
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